AC
SAGE

Amia Capital’s Sage Therapeutics SAGE Stock Holding History

Amia Capital’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,644
Closed -$467K – 24
2020
Q3 		$467K Buy
7,644
+447
+6% +$22.7K 0.54% 21
2020
Q2 		$299K Sell
7,197
-3,962
-36% -$144K 0.25% 28
2020
Q1 		$320K Sell
11,159
-2,882
-21% -$167K 0.28% 26
2019
Q4 		$1.01M Buy
+14,041
New +$1.73M 0.3% 25

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Amia Capital's SAGE Position: Q4 2020 in Review

Amia Capital sold out of Sage Therapeutics (SAGE) in Q4 2020, closing a stake of 7,644 shares — an estimated $467K sold.

Amia Capital first reported a position in SAGE in Q4 2019 and held it in 4 quarters. The position peaked at $1.01M in Q4 2019. 249 funds tracked by Wall St. Rank hold SAGE as of Q4 2020.

  • Amia Capital reported no remaining Sage Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Amia Capital sold 7,644 Sage Therapeutics shares in Q4 2020, an estimated $467K.
  • Amia Capital first reported a position in Sage Therapeutics in Q4 2019 and held it in 4 quarters.
  • Amia Capital's Sage Therapeutics position peaked at $1.01M in Q4 2019.
  • 249 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2020.

Based on Amia Capital's 13F filing for Q4 2020, filed 11 Feb 2021.